N. Oztop Et Al. , "Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study," ALLERGY AND ASTHMA PROCEEDINGS , vol.43, no.6, pp.519-528, 2022
Oztop, N. Et Al. 2022. Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study. ALLERGY AND ASTHMA PROCEEDINGS , vol.43, no.6 , 519-528.
Oztop, N., Demir, S., Unal, D., Beyaz, S., Terzioglu, K., Olgac, M., ... Gelincik, A.(2022). Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study. ALLERGY AND ASTHMA PROCEEDINGS , vol.43, no.6, 519-528.
Oztop, Nida Et Al. "Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study," ALLERGY AND ASTHMA PROCEEDINGS , vol.43, no.6, 519-528, 2022
Oztop, Nida Et Al. "Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study." ALLERGY AND ASTHMA PROCEEDINGS , vol.43, no.6, pp.519-528, 2022
Oztop, N. Et Al. (2022) . "Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study." ALLERGY AND ASTHMA PROCEEDINGS , vol.43, no.6, pp.519-528.
@article{article, author={Nida ÖZTOP Et Al. }, title={Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study}, journal={ALLERGY AND ASTHMA PROCEEDINGS}, year=2022, pages={519-528} }